Although a number of pharmacological properties have
been linked
to
Eucalyptus camaldulensis
leaf essential
oil and extracts, the biological attributes of the lipophilic fraction
remain unknown. Moreover, only a limited number of active compounds
have so far been identified. This work aimed to investigate the anti-oxidative,
anti-aggregation, and cytotoxic properties as well as profile the
secondary metabolites in the lipophilic fraction of
E. camaldulensis
leaf extract (Lipo-Eucam) using
UHPLC-ESI-QTOF-MS and gas chromatography–mass spectrometry
(GC–MS). It was found that Lipo-Eucam possessed potent antioxidant
properties against DPPH, ABTS, and FRAP with IC
50
values
of 31.46, 32.78, and 10.12 μg/mL, respectively. The fraction
was able to attenuate metal-catalyzed oxidation of bovine serum albumin
(BSA) in a dose-dependent manner (
p
< 0.05) and
abrogated the aggregation of amyloidogenic BSA as revealed by the
Congo red assay and transmission electron microscopy. Furthermore,
Lipo-Eucam demonstrated potent cytotoxic effects against MCF-7 (IC
50
7.34 μg/mL) but was noncytotoxic at used concentrations
against HEK-293 cells (IC
50
> 80 μg/mL), suggestive
of its selective anticancer properties. Spectrophotometric, UHPLC–MS,
and GC–MS analysis revealed that Lipo-Eucam is rich in phenolics,
flavonoids, terpenoids, volatile constituents, and a plethora of active
metabolites, probably responsible for the observed activities. These
findings indicate that Lipo-Eucam is endowed with pharmacologically
relevant active principles with strong potential for use in the amelioration
of disease conditions related to oxidative stress, protein aggregation,
and breast cancer and therefore worthy of further investigations.